Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features in a Primary Care Setting: A Pragmatic, Randomized, Single Blind Study
Latest Information Update: 24 Nov 2023
At a glance
- Drugs Vonoprazan (Primary) ; Omeprazole
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 20 Nov 2023 Status changed from recruiting to discontinued. Reason the study was stopped: Budget for the study was withdrawn and discontinued.
- 24 Jul 2019 New trial record